People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost ...

Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026Topline Results from North American Phase 3 ...

Please provide your email address to receive an email when new articles are posted on . Expanded access to DAAs led to a decline in hepatitis C infection and reinfection in people with HIV. The ...

People coinfected with HIV and hepatitis C virus remain at risk for hepatocellular carcinoma within 6 years of starting ...

Occult HCV and HBV infections are recently identified entities whose existence became evident when nucleic acid amplification assays of enhanced sensitivity were employed for the detection of viral ...

The hepatitis C virus—HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens of millions of people worldwide and there is no ...

To understand increasing rates of hepatitis C virus (HCV) infection in Tennessee, we conducted testing, risk factor analysis and a nested case–control study among persons who use drugs. During ...